6-42228523-G-A
Variant summary
Our verdict is Likely benign. The variant received -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001395490.1(TRERF1):c.3461C>T(p.Pro1154Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000452 in 1,614,156 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001395490.1 missense
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRERF1 | NM_001395490.1 | c.3461C>T | p.Pro1154Leu | missense_variant | Exon 18 of 18 | ENST00000695948.1 | NP_001382419.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRERF1 | ENST00000695948.1 | c.3461C>T | p.Pro1154Leu | missense_variant | Exon 18 of 18 | NM_001395490.1 | ENSP00000512293.1 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152198Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000875 AC: 22AN: 251342 AF XY: 0.0000957 show subpopulations
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461840Hom.: 0 Cov.: 31 AF XY: 0.0000605 AC XY: 44AN XY: 727214 show subpopulations
GnomAD4 genome AF: 0.0000328 AC: 5AN: 152316Hom.: 0 Cov.: 32 AF XY: 0.0000403 AC XY: 3AN XY: 74478 show subpopulations
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.3425C>T (p.P1142L) alteration is located in exon 18 (coding exon 14) of the TRERF1 gene. This alteration results from a C to T substitution at nucleotide position 3425, causing the proline (P) at amino acid position 1142 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at